Trinity Biotech (TRIB) Non Operating Income (2010 - 2024)
Trinity Biotech recorded quarterly Non Operating Income of $6.5 million in Q4 2024, up 388.6% quarter-over-quarter from -$2.2 million in Q3 2024, and up 473.87% year-over-year from $1.1 million in Q1 2024.
Trinity Biotech's Non Operating Income history runs 11 years deep, the most recent figure standing at $6.5 million for Q4 2024.
- In Q4 2024, Non Operating Income rose 473.87% year-over-year to $6.5 million; the TTM figure through Dec 2024 stood at $1.2 million (up 111.86% YoY), while the FY2025 annual figure was $202000.0, down 82.76% from the prior year.
- Non Operating Income came in at $6.5 million for Q4 2024 at Trinity Biotech, up from -$2.2 million in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $6.5 million in Q4 2024 to a low of -$12.0 million in Q1 2022.
- A 4-year average of -$2.7 million and a median of -$2.1 million in 2023 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income slumped 58.95% in 2022 and soared 473.87% in 2024, its largest moves.
- Trinity Biotech's Non Operating Income stood at -$1.2 million in 2021, then plunged by 58.95% to -$1.9 million in 2022, then grew by 6.95% to -$1.7 million in 2023, then jumped by 473.87% to $6.5 million in 2024.
- According to Business Quant data, Non Operating Income over the past three periods registered $6.5 million, -$2.2 million, and -$2.8 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.80 Mn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 6.45 Mn |
| Sep 30, 2024 | -2.24 Mn |
| Jun 30, 2024 | -2.84 Mn |
| Mar 31, 2024 | -209,000.00 |
| Dec 31, 2023 | -1.73 Mn |
| Sep 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | -3.76 Mn |
| Mar 31, 2023 | -2.40 Mn |
| Sep 30, 2022 | -1.86 Mn |
| Jun 30, 2022 | -8.30 Mn |
| Mar 31, 2022 | -12.00 Mn |
| Sep 30, 2021 | -1.17 Mn |
| Dec 31, 2016 | 3.90 Mn |
| Sep 30, 2016 | -3.09 Mn |
| Dec 31, 2015 | -82,000.00 |
| Sep 30, 2015 | 9.63 Mn |
| Jun 30, 2015 | -98,000.00 |
| Sep 30, 2014 | -6,000.00 |
| Jun 30, 2014 | -2,000.00 |
| Jun 30, 2013 | 440,000.00 |
| Dec 31, 2012 | 506,000.00 |
| Sep 30, 2012 | 571,000.00 |
| Dec 31, 2011 | 604,000.00 |
| Sep 30, 2011 | 546,000.00 |
| Dec 31, 2010 | 491,000.00 |
| Sep 30, 2010 | 445,000.00 |